Burlington, Massachusetts, November 13, 2017 — MilliporeSigma today launched the new Stericup® Quick Release 500 mL vacuum filtration system, a filter bottle system ideally suited for sterile filtration of cell culture media, buffers and reagents.
The Stericup® Quick Release system is the next generation of the original Stericup® Sterile Vacuum Filtration System, which has been a staple in labs around the world for decades. The improved liquid sterile filtration system offers ergonomic design updates that optimize user control and streamline the filtration process, while safeguarding results with the proven performance of Millipore® membranes.
“Life science researchers are under pressure to deliver innovative and reproducible results at an ever-increasing pace and with greater returns. Even seemingly routine processes like microfiltration must be reliable and consistent, because quality and reproducibility are critical to the cell culture process,” said Klaus Bischoff, Head of Research Solutions at MilliporeSigma.
MilliporeSigma’s Stericup® Quick Release system not only mitigates inherent pain points experienced by scientists during sterile filtration, like concerns over maintaining sterility and spillage, but also streamlines the overall process while establishing a foundation for reliability, consistency and confidence for steps downstream.
The Stericup® Quick Release combines a Steritop® filter unit with a re-designed Stericup® receiver bottle for storage of sterilized media, buffers and other liquid, and is offered in sizes in the 150 to 1,000mL volume range with multiple membrane materials and pore sizes ideal for the range of requirements. The Stericup® Quick Release system incorporates design enhancements that improve the user experience, including:
While changes to MilliporeSigma’s Stericup® filter provide an enhanced user experience, the membranes inside the filter remain the same, ensuring reliable filtration and confidence in downstream analysis, assay development and scientific reproducibility. Millipore® membranes are quality-tested and quality-validated for performance, and provide reliable filtration with high flow rates, low protein binding and low fluid retention, minimal fouling and assurance of sterility.
About the Life Science Business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 20,000 employees and 60 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.
Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.
Merck KGaA, Darmstadt, Germany, the vibrant science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2017, Merck KGaA, Darmstadt, Germany generated sales of €15.3 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.